Projects and Grants per year
Personal profile
Research Interests
Phase I investigations, lung cancer, head and neck cancer, radiation-chemotherapy interactions, population studies in Appalachia.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, University Of Kentucky
1998
Doctor of Medicine, University Of Kentucky
1992
Bachelor of Arts, Brown University
1985
Residency, University Of Virginia
1985
Fingerprint
Dive into the research topics where Susanne M Arnold is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
25-HN-43-PDS (PDS0101-HNC-301): A Phase 3 Open-Label, Randomized Study of PDS0101 Plus Pembrolizumab vs Pembrolizumab Alone in First Line Treatment of Immune Checkpoint Inhibitor (ICI) Naive Subjects with Unresectable Recurrent and/or Metastatic (R/M) Hum
Arnold, S. M. (PI)
8/21/25 → 8/21/27
Project: Research project
-
24-HN-42-BT(BCA101X301): A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination with Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carc
Arnold, S. M. (PI)
Bicara Therapeutics Incorporated
4/21/25 → 4/21/27
Project: Research project
-
WCG-25-LUN115I-MSD-PMC: Substudy 01I: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC)
Arnold, S. M. (PI)
Merck Sharp & Dohme Corporation
9/20/24 → 9/20/26
Project: Research project
-
WCG-25-LUN-115H-MSD-PMC: Substudy 01H: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants with Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC)
Arnold, S. M. (PI)
Merck Sharp & Dohme Corporation
9/20/24 → 9/20/26
Project: Research project
-
Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN)
Coghill, A. E., Van Bibber, N., Baiocchi, R. A., Arnold, S. M., Riedlinger, G., Schneider, B. P., Zhang, Y., Suneja, G., Fontela, M. G., Abate-Daga, D. & Teer, J. K., May 1 2025, In: Cancer Epidemiology Biomarkers and Prevention. 34, 5, p. 774-779 6 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility loci
INTEGRAL-ILCCO Consortium, Jul 15 2025, In: Human Molecular Genetics. 34, 14, p. 1227-1237 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Cognetti, D. M., Curry, J. M., Johnson, J., Kwon, M., Su, S. Y., Civantos, F., Olazagasti, C., Valentino, J., Arnold, S., Bell, R. B., Gibson, M. K., Mannion, K., Van Abel, K. M., Price, K. A., Dong, H., Thorne, A. H., Suzuki, T. & Gillenwater, A. M., 2025, (Accepted/In press) In: Head and Neck.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer
Morgensztern, D., Ready, N., Johnson, M. L., Dowlati, A., Choudhury, N., Carbone, D. P., Schaefer, E., Arnold, S. M., Puri, S., Piotrowska, Z., Hegde, A., Chiang, A. C., Iams, W., Tolcher, A., Nosaki, K., Kozuki, T., Li, T., Santana-Davila, R., Akamatsu, H. & Murakami, H. & 8 others, , Nov 15 2024, In: Clinical Cancer Research. 30, 22, p. 5042-5052 11 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity
Wang, M., Xie, Y., Liu, J., Li, A., Chen, L., Stromberg, A., Arnold, S. M., Liu, C. & Wang, C., Jul 2024, In: Cancers. 16, 13, 2488.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations